![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Wuxi Fortune Pharmaceutical Co., Ltd. Wuxi Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Spiramycin, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2014-062 - Rev 00
This Chemical Type CEP, issued on February 22, 2016, remains in force until February 22, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 293 associated with this CEP further emphasizes